Plain-English translation of NCT06435156 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This is a study testing whether a medication called can help people who have both type 1 diabetes and heart failure. Half of the participants will take once daily for 16 weeks, while the other half will take a placebo (a pill with no active ingredient) so researchers can fairly compare how well the medication works. The goal is to see if this treatment can improve heart function and quality of life in this group of patients.
Heart failure is becoming more common in people with type 1 diabetes, and current treatments don't work well enough for everyone. Researchers believe this medication may help protect the heart and reduce the burden of heart failure symptoms in this population.
You likely qualify if…
You likely don't qualify if…
You will take one tablet by mouth once daily for 16 weeks—either the study medication or a placebo. You'll need to use a continuous glucose monitor to track your blood sugar throughout the trial. You will have screening visits to confirm you qualify, then regular follow-up appointments where doctors will check your heart function, ask about your symptoms, and monitor your overall health to see how the treatment is working.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
United Kingdom